VAERS reports by lot

Merck MMR lot T033814: VAERS reports

40 VAERS reports list lot T033814 as a Merck MMR vaccine, received between 2021-12-17 and 2023-07-24. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
40
Reports
0%
Marked serious
0
With a death outcome
10
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Dermatological (non-injection-site)240%
General / Systemic (non-local)240%
Cardiac / Cardiovascular120%

Where reports came from

U.S. state of the reporter, where given (top 9).

New York29
Texas2
Ohio2
Louisiana2
Alabama1
New Jersey1
New Hampshire1
California1
Minnesota1

Reports by month received

2021-121
2022-0128
2022-041
2022-052
2022-071
2022-102
2022-112
2022-121
2023-011
2023-071

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.